Streamline Health Solutions Profit Margin 2010-2023 | STRM
Current and historical gross margin, operating margin and net profit margin for Streamline Health Solutions (STRM) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Streamline Health Solutions net profit margin as of October 31, 2023 is -81.36%.
| Streamline Health Solutions Annual Profit Margins |
|---|
| Streamline Health Solutions Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.020B | $0.025B |
| Streamline Health Solutions, Inc. is a leading supplier of workflow and document management tools, applications and services that assist strategic business partners and healthcare organizations to improve operational efficiencies through business process optimization. The Company provides integrated tools and technologies for automating document-intensive environments, including document workflow, document management, e-forms, portal connectivity, optical character recognition and interoperability. The Company's workflow-based services offer solutions to inefficient and labor-intensive healthcare business processes throughout the revenue cycle, such as chart coding, abstracting and completion, remote physician order processing, pre-admission registration scanning and signature capture, insurance verification, secondary billing services, explanation of benefits processing and release of information processing. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $38.473B | 21.40 |
| Inspire Medical Systems (INSP) | United States | $6.824B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.536B | 0.00 |
| Axonics (AXNX) | United States | $3.409B | 0.00 |
| 10x Genomics (TXG) | United States | $3.313B | 0.00 |
| Enovis (ENOV) | United States | $3.044B | 23.13 |
| Azenta (AZTA) | United States | $2.839B | 231.41 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.739B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.545B | 0.00 |
| Privia Health (PRVA) | United States | $2.142B | 95.00 |
| Schrodinger (SDGR) | United States | $1.771B | 0.00 |
| Omnicell (OMCL) | United States | $1.294B | 31.66 |
| Phreesia (PHR) | United States | $1.264B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.863B | 0.00 |
| Standard BioTools (LAB) | United States | $0.737B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.615B | 0.00 |
| Talkspace (TALK) | United States | $0.519B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.327B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.326B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.308B | 0.00 |
| Pulmonx (LUNG) | United States | $0.285B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.171B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.165B | 0.00 |
| American Well (AMWL) | United States | $0.160B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.150B | 0.00 |
| Augmedix (AUGX) | United States | $0.146B | 0.00 |
| Outset Medical (OM) | United States | $0.121B | 0.00 |
| TruBridge (TBRG) | United States | $0.121B | 5.15 |
| 111 (YI) | China | $0.089B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.079B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.043B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Movano (MOVE) | United States | $0.026B | 0.00 |
| Cue Health (HLTH) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| Akili (AKLI) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.015B | 0.00 |
| Biotricity (BTCY) | United States | $0.014B | 0.00 |
| Centogene (CNTG) | Germany | $0.013B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |